Comparing two blood tests for sepsis in ICUs
Part of Infections clinical trials.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You have a lung infection (like pneumonia) and are in the ICU.
- Doctors have confirmed you have sepsis (a serious infection response).
- You are not pregnant.
- You do not have cancer, severe liver or kidney problems, or had recent intestinal surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is comparing two blood tests (Interleukin 6 and Procalcitonin) to find which is better at detecting sepsis (a serious infection) and predicting the risk of death in burn patients in the ICU. If you have moderate burns and are otherwise healthy, this trial could help improve care for burn victims.
This study is testing two different simple blood tests to see which one better predicts sepsis (a severe infection response) and outcomes in ICU patients after surgery or trauma. It aims to help doctors identify high-risk patients sooner and improve care.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.